BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 30108055)

  • 1. Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments.
    Liao H; Ji F; Helleday T; Ying S
    EMBO Rep; 2018 Sep; 19(9):. PubMed ID: 30108055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RecQ Family Helicases in Replication Fork Remodeling and Repair: Opening New Avenues towards the Identification of Potential Targets for Cancer Chemotherapy.
    Jain CK; Mukhopadhyay S; Ganguly A
    Anticancer Agents Med Chem; 2020; 20(11):1311-1326. PubMed ID: 32418530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells.
    Datta A; Biswas K; Sommers JA; Thompson H; Awate S; Nicolae CM; Thakar T; Moldovan GL; Shoemaker RH; Sharan SK; Brosh RM
    Nat Commun; 2021 Nov; 12(1):6561. PubMed ID: 34772932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High speed of fork progression induces DNA replication stress and genomic instability.
    Maya-Mendoza A; Moudry P; Merchut-Maya JM; Lee M; Strauss R; Bartek J
    Nature; 2018 Jul; 559(7713):279-284. PubMed ID: 29950726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication fork stability confers chemoresistance in BRCA-deficient cells.
    Ray Chaudhuri A; Callen E; Ding X; Gogola E; Duarte AA; Lee JE; Wong N; Lafarga V; Calvo JA; Panzarino NJ; John S; Day A; Crespo AV; Shen B; Starnes LM; de Ruiter JR; Daniel JA; Konstantinopoulos PA; Cortez D; Cantor SB; Fernandez-Capetillo O; Ge K; Jonkers J; Rottenberg S; Sharan SK; Nussenzweig A
    Nature; 2016 Jul; 535(7612):382-7. PubMed ID: 27443740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tough row to hoe: when replication forks encounter DNA damage.
    Patel DR; Weiss RS
    Biochem Soc Trans; 2018 Dec; 46(6):1643-1651. PubMed ID: 30514768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Kinases: Targeting Replication Stress Proteins in Cancer Therapy.
    Baillie KE; Stirling PC
    Trends Cancer; 2021 May; 7(5):430-446. PubMed ID: 33203609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors.
    Lappin KM; Barros EM; Jhujh SS; Irwin GW; McMillan H; Liberante FG; Latimer C; La Bonte MJ; Mills KI; Harkin DP; Stewart GS; Savage KI
    Cancer Res; 2022 Mar; 82(5):819-830. PubMed ID: 35027467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EXD2 Protects Stressed Replication Forks and Is Required for Cell Viability in the Absence of BRCA1/2.
    Nieminuszczy J; Broderick R; Bellani MA; Smethurst E; Schwab RA; Cherdyntseva V; Evmorfopoulou T; Lin YL; Minczuk M; Pasero P; Gagos S; Seidman MM; Niedzwiedz W
    Mol Cell; 2019 Aug; 75(3):605-619.e6. PubMed ID: 31255466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse embryonic stem cells have increased capacity for replication fork restart driven by the specific Filia-Floped protein complex.
    Zhao B; Zhang W; Cun Y; Li J; Liu Y; Gao J; Zhu H; Zhou H; Zhang R; Zheng P
    Cell Res; 2018 Jan; 28(1):69-89. PubMed ID: 29125140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stalled replication forks: making ends meet for recognition and stabilization.
    Masai H; Tanaka T; Kohda D
    Bioessays; 2010 Aug; 32(8):687-97. PubMed ID: 20658707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair.
    Ying S; Chen Z; Medhurst AL; Neal JA; Bao Z; Mortusewicz O; McGouran J; Song X; Shen H; Hamdy FC; Kessler BM; Meek K; Helleday T
    Cancer Res; 2016 Mar; 76(5):1078-88. PubMed ID: 26603896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation.
    Rondinelli B; Gogola E; YĆ¼cel H; Duarte AA; van de Ven M; van der Sluijs R; Konstantinopoulos PA; Jonkers J; Ceccaldi R; Rottenberg S; D'Andrea AD
    Nat Cell Biol; 2017 Nov; 19(11):1371-1378. PubMed ID: 29035360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of ubiquitination and the maintenance of replication fork stability in cancer therapy.
    Xia D; Zhu X; Wang Y; Gong P; Su HS; Xu X
    Biosci Rep; 2023 Oct; 43(10):. PubMed ID: 37728310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition.
    Berti M; Ray Chaudhuri A; Thangavel S; Gomathinayagam S; Kenig S; Vujanovic M; Odreman F; Glatter T; Graziano S; Mendoza-Maldonado R; Marino F; Lucic B; Biasin V; Gstaiger M; Aebersold R; Sidorova JM; Monnat RJ; Lopes M; Vindigni A
    Nat Struct Mol Biol; 2013 Mar; 20(3):347-54. PubMed ID: 23396353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct functions of human RecQ helicases during DNA replication.
    Urban V; Dobrovolna J; Janscak P
    Biophys Chem; 2017 Jun; 225():20-26. PubMed ID: 27876204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers.
    Mondal G; Stevers M; Goode B; Ashworth A; Solomon DA
    Nat Commun; 2019 Apr; 10(1):1686. PubMed ID: 30975996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Rad52-dependent replication fork recovery through serine ADP-ribosylation of PolD3.
    Richards F; Llorca-Cardenosa MJ; Langton J; Buch-Larsen SC; Shamkhi NF; Sharma AB; Nielsen ML; Lakin ND
    Nat Commun; 2023 Jul; 14(1):4310. PubMed ID: 37463936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing replication fork collapse to maintain genome integrity.
    Cortez D
    DNA Repair (Amst); 2015 Aug; 32():149-157. PubMed ID: 25957489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication stress induces specific enrichment of RECQ1 at common fragile sites FRA3B and FRA16D.
    Lu X; Parvathaneni S; Hara T; Lal A; Sharma S
    Mol Cancer; 2013 Apr; 12(1):29. PubMed ID: 23601052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.